AB Active ETFs- AB Corporate Bond ETF Return on Equity

The latest ROE for EYEG is -65.18%. That is below the Healthcare sector average of 20.86%. Investors often review this figure alongside AB Active ETFs- AB Corporate Bond ETF's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, EYEG currently prints -65.18% for ROE, while the sector average sits near 20.86%. That is roughly 412.5% below the sector mean. Large gaps often invite a closer look at AB Active ETFs- AB Corporate Bond ETF's growth, margins, and balance sheet.

Return on Equity shows how effectively AB Active ETFs- AB Corporate Bond ETF converts resources into returns. At -65.18%, EYEG may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting EYEG's ROE (-65.18%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack AB Active ETFs- AB Corporate Bond ETF's ROE against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.